Plain-English translation of NCT05717179 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Rheumatoid arthritis is an autoimmune disease that causes joint inflammation and pain. This trial is testing whether adding ultrasound imaging of your joints to guide treatment decisions—alongside the usual clinical evaluation—helps people better control their disease. The goal is to see if ultrasound can help doctors make smarter choices about which medications to use or adjust.
Some people with rheumatoid arthritis have ongoing disease activity even while taking medication, and doctors sometimes struggle to tell whether inflammation is truly present or how much. Ultrasound can visualize inflammation that isn't always obvious from symptoms alone, so this trial is testing whether using this technology helps doctors catch hidden inflammation earlier and make better treatment adjustments.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will receive treatment adjustments over 24 weeks based on standard clinical assessment. The ultrasound group will have additional ultrasound scans of 44 joints at the start and at the 12-week mark to help guide medication decisions. Your disease activity will be measured at week 24 to see if you've reached low disease activity or remission. Throughout the study, you'll have regular visits with your rheumatologist to monitor how you're responding to treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy